DEFB103A Antikörper
(1 reference)-
- Target Alle DEFB103A Antikörper anzeigen
- DEFB103A (Defensin, beta 103A (DEFB103A))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DEFB103A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Isotyp
- IgG
- Top Product
- Discover our top product DEFB103A Primärantikörper
-
anti-Defensin, beta 103A (DEFB103A) (AA 23-67) antibody
DEFB103A Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Defensin, beta 103A (DEFB103A) (AA 1-67) antibodyDEFB103A Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Defensin, beta 103A (DEFB103A) (AA 6-22) antibodyDEFB103A Reaktivität: Human, Ratte WB, EIA, IHC (p), RIA Wirt: Maus Monoclonal L3-18b-E1 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1.0 mg/mL
-
-
: "Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic." in: The Journal of biological chemistry, Vol. 276, Issue 8, pp. 5707-13, (2001) (PubMed).
-
: "Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic." in: The Journal of biological chemistry, Vol. 276, Issue 8, pp. 5707-13, (2001) (PubMed).
-
- Target
- DEFB103A (Defensin, beta 103A (DEFB103A))
- Andere Bezeichnung
- DEFENSIN beta 3 (DEFB103A Produkte)
- Hintergrund
- Synonyms: BD-3
- Gen-ID
- 55894
- UniProt
- P81534
- Pathways
- Production of Molecular Mediator of Immune Response
-
